Affinity Asset Advisors, LLC 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-14 4:13 pm Purchase | 2026-03-31 | 13G | SUTRO BIOPHARMA INC STRO | Affinity Asset Advisors, LLC | 1,069,519 6.500% | 321,137 (+42.91%) | Filing |
| 2026-01-29 7:58 pm Purchase | 2026-01-22 | 13G | SUTRO BIOPHARMA INC STRO | Affinity Asset Advisors, LLC | 748,382 8.800% | 90,005 (+13.67%) | Filing |